Androstenedione is a steroid hormone produced by the adrenal glands and gonads, serving as a precursor for testosterone and estrogen. It is measured to evaluate adrenal and gonadal function.
Androstendion is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Androstendion is especially relevant when fatigue overlaps with brain fog, concentration problems, paresthesias, or other neurologically flavored symptoms. Even then, one value alone rarely resolves the whole picture.
Androstendion does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Androstenedione is a weak androgen mainly produced in the adrenal glands and, to a lesser extent, in the ovaries and testes. It plays a central role in the biosynthesis of more potent sex hormones, testosterone and estrogen. While it has only mild androgenic activity itself, androstenedione is a crucial intermediate in the steroid hormone pathway.
Measurement of androstenedione levels in the blood helps assess adrenal and gonadal function and is often used in the workup of conditions such as congenital adrenal hyperplasia, polycystic ovary syndrome (PCOS), and certain adrenal tumors. Levels can vary with age, sex, and menstrual cycle phase.
Low androstenedione levels, typically below 0.3 ng/mL (1.0 nmol/L) in premenopausal women, may suggest adrenal insufficiency, such as in Addison's disease, or hypogonadism. It can also occur with surgical removal of the adrenal glands or with use of corticosteroid medications. In some cases, low levels may be noted in postmenopausal women as ovarian production declines. Reference ranges are lab-dependent and differ by sex and age.
Elevated androstenedione, generally above 3.5 ng/mL (12.1 nmol/L) for premenopausal women, can occur in conditions such as congenital adrenal hyperplasia (due to enzyme deficiencies), polycystic ovary syndrome (PCOS), or androgen-producing adrenal or ovarian tumors. High levels may also be seen in Cushing's syndrome. Interpretation depends on sex, age, and concurrent hormone measurements. All cutoffs are lab-dependent.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Androstendion is especially relevant when fatigue overlaps with brain fog, concentration problems, paresthesias, or other neurologically flavored symptoms. Even then, one value alone rarely resolves the whole picture.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Androstenedione (A4) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Normal ranges vary by sex, age, and menstrual phase. For premenopausal women, a typical range is 0.3–3.5 ng/mL (1.0–12.1 nmol/L); for men, it is around 0.6–3.1 ng/mL (2.1–10.8 nmol/L). Postmenopausal women often have lower levels. Because reference ranges are lab-dependent, always use the values provided by your testing laboratory.
High androstenedione may indicate an overproduction of androgens, often seen in congenital adrenal hyperplasia, polycystic ovary syndrome (PCOS), or adrenal tumors. It can also be elevated in Cushing's syndrome. Further testing is usually needed to determine the exact cause.
Low levels may be due to adrenal insufficiency (Addison's disease), hypogonadism, or surgical removal of the adrenal glands. Corticosteroid therapy can also suppress production. Low results in elderly women are often normal due to decreased ovarian output.
It is used to evaluate adrenal and gonadal function, particularly when investigating symptoms of excess androgens (such as hirsutism or irregular periods) or adrenal disorders. It is often ordered alongside other hormone tests like testosterone and DHEA-S.
Androstendion does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
Androstendion is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
Markers linked to sleep, stress, recovery, hormones, or metabolism often become more useful when viewed through pacing and daily load management.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
These references support the information presented on this page.
https://www.gesundheits-lexikon.com/Labormedizin-Labordiagnostik/Hormondiagnostik/Androstendion
gesundheits-lexikon.com
https://www.endokrinologikum-aesculabor.de/leistungsverzeichnis/hormone/parameter/androstendion.html
endokrinologikum-aesculabor.de
https://www.institutobernabeu.com/de/blog/hyperandrogenamie-ursachen-und-losungen/
institutobernabeu.com
https://www.med4you.at/laborbefunde/lbef3/lbef_androstendion_frau.htm
med4you.at
https://de.wikipedia.org/wiki/Androstendion
de.wikipedia.org
https://leistungsverzeichnis.labor-gaertner.de/entry/157
leistungsverzeichnis.labor-gaertner.de
https://www.kepleruniklinikum.at/FileDownload/18742?forceDownload=True
kepleruniklinikum.at
https://www.laborteam.ch/de/profile/268
laborteam.ch
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
